This study aimed to investigate the role of TMEM59L in regulating PTPRN‐mediated DNA damage repair and its impact on 5‐FU sensitivity in colorectal cancer, with the goal of identifying potential therapeutic targets to overcome chemoresistance. This evidence concerns the gene PTPRN and colorectal cancer.